Reduced transfusion rate without increase in VTE rate with erythropoietin in orthopaedic surgery
Reduced transfusion rate without increase in VTE rate with erythropoietin in orthopaedic surgery
A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty
Ther Clin Risk Manag. 2018 Jul 10;14:1191-1204. doi: 10.2147/TCRM.S159134Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
25 randomized controlled trials were included in this meta-analysis which assessed results related to transfusion rate, hemoglobin levels, and venous thromboembolism rate associated with erythropoietin (EPO) administration in orthopaedic surgery. Comparisons included EPO to inactive control treatment, EPO to active control treatment with preoperative autologous blood donation, and the combination ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.